Yunlong Wang

Henan Purui Pharmaceutical is a biotechnology company founded by Professor Yunlong Wang, a prominent scientist at Zhengzhou University and director of the Henan Bioengineering Research Center. The company specializes in the development and commercialization of recombinant vaccines, diagnostic reagents, and innovative drug delivery systems. Its core technology platform utilizes virus-like particles (VLPs) for the creation of high-efficacy vaccines against infectious diseases such as hepatitis B and influenza, as well as targeted cancer therapies. Henan Purui is a key player in the regional biotech ecosystem in Zhengzhou, China, maintaining close ties with academic institutions and major diagnostic companies like Antu Bio. The company's portfolio includes a range of IVD (in vitro diagnostic) products and ongoing research into nanoparticle-based theranostics.